ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.508,67
1,09%
S&P 500
5.127,79
1,26%
US Dollar vs BRL
5,0724
0,00%
Bitcoin
63.882,41
-0,02%
Brent Oil
82,765
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Panbela Therapeutics Inc (PBLA)

  7. Panbela Therapeutics Inc (PBLA) Notícias

PBLA Panbela Therapeutics Inc

1,11
0,00 (0,00%)
02 Mai 2024 - Fechado
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Panbela Therapeutics Inc PBLA NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,00 0,00% 1,11 21:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
1,11 1,11
mais cotações »

Notícias Recentes

Data Hora Fonte Título
01/05/202417:15GLOBEPanbela to Host First Quarter 2024 Earnings Conference Call..
30/04/202409:00GLOBEAcceptance of Eflornithine (DFMO) Abstract for Oral..
22/04/202409:00GLOBEPanbela Therapeutics Announces Interim Data Analysis for..
18/04/202409:00GLOBEPanbela Announces Poster Presentation at American..
16/04/202418:29GLOBEPanbela Announces Transfer to OTCQB Market
26/03/202417:10GLOBEPanbela Provides Business Update and Reports Q4 and FY 2024..
26/03/202408:21IHMARKETNEWSU.S. Index Futures on the Rise, Oil Prices Show Stability
12/03/202417:15GLOBEPanbela to Host Fourth Quarter and Year End 2023 Earnings..
15/02/202410:00GLOBEPanbela Regains Compliance with Nasdaq Listing Standards for..
01/02/202409:00GLOBEPanbela Announces Closing of Approximately $9.0 Million..
30/01/202410:15GLOBEAcceptance of Ivospemin (SBP-101) Abstract for Poster..
29/01/202408:15GLOBEPanbela Announces Pricing of Approximately $9.0 Million..
25/01/202409:00GLOBEPanbela Exceeds 50% Enrollment for Aspire Trial in..
18/01/202410:15GLOBEPanbela Announces Publication of Clinical Data Titled: Phase..
16/01/202410:00GLOBEPanbela Announces 1-for-20 Reverse Stock Split Effective..
21/12/202311:15GLOBEPanbela Therapeutics Announces Exercise of Warrants and..
18/12/202310:15GLOBEPanbela Therapeutics Announces US WorldMeds NDA Approval for..
04/12/202310:00GLOBEPanbela Announces Publication of Abstract Titled: Evaluation..
29/11/202310:15GLOBEPanbela Announces 2nd Independent Safety Review of the..
09/11/202318:10GLOBEPanbela Provides Business Update and Reports Q3 2023..
03/11/202308:55GLOBEPanbela Therapeutics Announces Exercise of Warrants and..
02/11/202309:15GLOBEPanbela Announces Publication of Preclinical and Clinical..
31/10/202309:15GLOBEPanbela Announces Validation of European Patent in UK,..
25/10/202309:15GLOBEAcceptance of Polyamine Inhibitor CAR-T Combination Abstract..
24/10/202309:15GLOBEPanbela to Host Third Quarter 2023 Earnings Conference Call..
26/09/202309:15GLOBEPanbela Announces Issuance of New Patent in China for Claims..
19/09/202309:15GLOBEPanbela to Present at the LD Micro Investor Conference
05/09/202309:15GLOBEPanbela Announces Issuance of New Patent in Chile for Claims..
28/08/202309:15GLOBEPanbela to Present at H.C. Wainwright 25th Annual Global..
14/08/202309:15GLOBEPanbela Announces Issuance of New Patent in Europe for..
10/08/202317:10GLOBEPanbela Provides Business Update and Reports Q2 2023..
31/07/202317:15GLOBEPanbela to Host Second Quarter 2023 Earnings Conference Call..
24/07/202309:15GLOBEPanbela Opens Enrollment in UK and Germany for Aspire Trial..
19/07/202309:00GLOBEPanbela Therapeutics to Receive a Total Up to $9.5 Million..
17/07/202307:00GLOBEPanbela Announces Issuance of New Patent in Australia Patent..
10/07/202309:15GLOBEPanbela Announces Preliminary Safety Analysis for ASPIRE..
28/06/202309:15GLOBEPanbela Announces PACES S0820 Phase III Trial Passes..
26/06/202309:15GLOBEPanbela Announces Poster Presentation at the Endocrine..
21/06/202317:15GLOBEPanbela Announces Closing of Approximately $8.5 Million..
16/06/202309:15GLOBEPanbela Announces Pricing of Approximately $8.5 Million..
13/06/202309:15GLOBEPanbela Announces Sponsored Research Agreement to Evaluate..
01/06/202309:15GLOBEPanbela Announces Poster Presentation at Immunology of..
31/05/202309:00GLOBEPanbela Announces 1-for-30 Reverse Stock Split Effective..
22/05/202309:15GLOBEPanbela Announces Clinical Trial with Moffitt Cancer Center..

Seu Histórico Recente

NASDAQ
PBLA
Panbela Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados